Publications by authors named "M Paccalin"

Claim this Profile
K
Ketoacidosis associated with type 2 sodium-glucose cotransporter inhibitors (SGLT2i) in patients aged 65 and older: Evidence from the French national pharmacovigilance database.
Nathanaël Bassas Letissier, Nassir Mirfendereski, Marie-Laure Laroche, Jean-Luc Faillie, Marc Paccalin

Diabetes Metab· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evaluation of subcutaneous amoxicillin/clavulanic acid pharmacokinetics as an alternative to the intravenous route in older patients-the PhASAge Study.
Nicolas Grégoire, David Mbarga, Hélène Mirfendereski, Françoise Stanke-Labesque, Dominique Breilh, Marc Paccalin

J Antimicrob Chemother· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Neutrophil-to-lymphocyte ratio, a predictor for mortality and unplanned hospital readmissions in patients aged 75 years and older with cancer.
Giorgia Ceci Barcaglioni, Julie Tisserand, Simon Valero, Patrick Bouchaert, Mélanie Bouisset, Marc Paccalin

J Geriatr Oncol· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Remote monitoring in older adults with cancer, opportunities and challenges: a narrative review.
Evelyne Liuu, Nicolò Matteo Luca Battisti, Angeline Galvin, Sarah Compton, Tania Kalsi, Marc Paccalin

Aging Clin Exp Res· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pharmacokinetics of Subcutaneous and Intravenous Ceftriaxone in an Older Population: The PhASAge Study.
Claire Roubaud-Baudron, Héloïse Fauchon, Françoise Stanke-Labesque, Marc Paccalin, Dominique Breilh

Open Forum Infect Dis· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis